ACE and chronic kidney disease: This could be attributed to only three (out of five) studies reporting the use of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers in patients [17, 48, 56], which reduce proteinuria and subsequently slow the progression of CKD [65].